Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma
- PMID: 32562363
- DOI: 10.1002/art.41406
Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma
Abstract
You are consulted to evaluate a 56-year-old woman with known Raynaud's phenomenon, finger swelling of several; months' duration, and new hypertension with a blood pressure of 160/100 mm/Hg. She also reports progressive shortness of breath. Physical examination reveals telangiectasias, sclerodactyly, and proximal skin sclerosis (thick shiny skin on the chest and upper arms), and bibasilar crackles are found on chest examination. Laboratory tests reveal evidence of microangiopathic hemolytic anemia, thrombocytopenia, and elevation of the serum creatinine level (previously normal), and chest computed tomography shows evidence of ground-glass opacification in both lower lung fields.
© 2020, American College of Rheumatology.
References
-
- Sackett D. Evidence-based medicine [letter]. Lancet 1995;346:1171.
-
- Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't [editorial]. BMJ 1996;312:71-2.
-
- Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis [review]. Nat Rev Dis Primers 2015;1:15002.
-
- Simms R. Assessment and management of progressive skin involvement in diffuse scleroderma. In: Varga J, Denton CP, Wigley FM, Allanore Y, Kuwana M, editors. Scleroderma. New York: Springer Science; 2017. p. 489-98.
-
- Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990;33:1256-63.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
